Stocks in Action: Sartorius Stedim Biotech, Süss Microtec, JENOPTIK, Vonovia, and RTL Group.
Reading Time: 3 minutes
Stock 1.) Sartorius Stedim Biotech benefits from increasing R&D investments in the pharma and biotech sector, Goldman Sachs raises to Buy with a price target of 214 Euros! A noteworthy Buy rating comes on Monday from Goldman Sachs analysts for Sartorius Stedim Biotech. The subsidiary of the life sciences specialist Sartorius is a key player in biopharmaceuticals, providing manufacturers of biopharmaceuticals with solutions in cell cultivation, fermentation, filtration, purification, and fluid management. This positions the company to benefit...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
